| ARCT latest price $96.3200 (2.79%) ($89.7400 - $97.9300) on Fri. Sep. 6, 2013. |
|
|
| Trend Analysis and Forecast |
| |
Average Daily Percentage Swing | 4.74% (three month average) |
RSI | 49 |
Latest Price | $96.3200(2.79%) |
Stocks Behave Similarly | Similar Stock List |
Daily Trend | ARCT advances 1% a day on average for past five trading days. |
Weekly Trend | ARCT declines -2.1% a week on average for past two weeks. |
Market Behavior | Normal for large cap. Normal for small cap. |
Correlated ETFs | Broad market will support ARCT advance at 0% a week (0% probability) IWM(4%) XOP(4%) VWO(2%) BNDX(1%) EEM(1%) |
Factors Impacting ARCT price | ARCT will decline at least -2.37% in a week (0% probabilities). LQD(-4%) XLU(-3%) IGOV(-2%) GLD(-2%) XLP(-1%) |
Explanation | The rally is not sustainable and not supported by the broad market. |
| |
| |
Relative Volatility | (options are extremely cheap) |
| |
Market Trend Strength | -2.37% (StdDev 4.74%) |
Hourly BBV | 0 () |
Intraday Trend | 5.2% |
| |
|
|
July 7, 2020 ARCT develops mRNA based covid vaccine. Now it's still in preclinical stage, and plan to start phase I clinic trail this summer.